Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Jon C. Ogg | May 1, 2018 at 12:15 PM EDT

Will a PCSK9 Inhibitor Price Cut Help Drive Lowering LDL-Cholesterol Drug Use?

Regeneron Pharmaceuticals and Sanofi are committing to lowering the price of the anti-cholesterol drug Praluent.

Chris Lange | May 1, 2018 at 12:05 PM EDT

Will Gilead Sciences Earnings Get a Boost From a Collaboration?

Gilead Sciences is set to report its most recent quarterly results after the markets close on Tuesday, the first since…

Jon C. Ogg | May 1, 2018 at 10:50 AM EDT

Why One Old Stock Buyback Trick Is Working So Well for AbbVie

AbbVie is trying one of the older and less-used efforts to drive its share price back up: a modified Dutch…

Chris Lange | May 1, 2018 at 10:20 AM EDT

How Keytruda Saved Merck’s Q1

Merck released better-than-expected quarterly results and full-year guidance before the markets opened on Tuesday.

Chris Lange | May 1, 2018 at 9:55 AM EDT

How Much Pfizer Earnings Depend on a Few Brands

Pfizer reported mixed first-quarter financial results and full-year guidance before the markets opened on Tuesday.

Chris Lange | Apr 30, 2018 at 1:25 PM EDT

What to Look For in the Merck and Pfizer Reports Tuesday Morning

Both Pfizer and Merck are scheduled to release their most recent quarterly results before the markets open on Tuesday. These…

Chris Lange | Apr 30, 2018 at 10:20 AM EDT

Evelo Announces Potential Pricing for IPO

Evelo Biosciences expects to price its more than 5 million shares in a range that results in an initial public…

Chris Lange | Apr 30, 2018 at 9:50 AM EDT

Why SteadyMed Shares Are Skyrocketing

SteadyMed saw its shares skyrocket early on Monday after the company announced that it would be acquired by United Therapeutic.

Jon C. Ogg | Apr 26, 2018 at 11:05 AM EDT

Johnson & Johnson Commits to Yet Another Dividend Hike

Johnson & Johnson just delivered yet another dividend hike. The company previously had committed to increasing its dividends over and…

Chris Lange | Apr 26, 2018 at 10:55 AM EDT

How Alexion Pharmaceuticals Knocked It Out of the Park in Q1

Alexion Pharmaceuticals released better-than-expected first-quarter financial results before the markets opened on Thursday.

Chris Lange | Apr 25, 2018 at 8:40 AM EDT

Major Biotechs Face Rising Tide of Short Interest

The April 13 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Apr 25, 2018 at 8:35 AM EDT

Short Sellers Grow More Selective on Major Pharma Stocks

The April 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Apr 24, 2018 at 12:20 PM EDT

Why Eli Lilly’s Big Earnings Beat, Rosy Guidance Were Not Enough

Eli Lilly released its most recent quarterly earnings report before the markets opened on Tuesday.

Chris Lange | Apr 24, 2018 at 11:30 AM EDT

Unity Biotech Announces Potential Pricing for IPO

Unity Biotechnology plans to offer 5 million shares in an initial public offering valued up to more than $103 million.

Chris Lange | Apr 24, 2018 at 10:10 AM EDT

Can Epizyme Survive This FDA Hold?

Epizyme shares tumbled on Tuesday after the FDA announced a partial clinical hold affecting new enrollment of patients in the…

1 … 134 135 136 137 138 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Will a PCSK9 Inhibitor Price Cut Help Drive Lowering LDL-Cholesterol Drug Use?

Will Gilead Sciences Earnings Get a Boost From a Collaboration?

Why One Old Stock Buyback Trick Is Working So Well for AbbVie

How Keytruda Saved Merck’s Q1

How Much Pfizer Earnings Depend on a Few Brands

What to Look For in the Merck and Pfizer Reports Tuesday Morning

Evelo Announces Potential Pricing for IPO

Why SteadyMed Shares Are Skyrocketing

Johnson & Johnson Commits to Yet Another Dividend Hike

How Alexion Pharmaceuticals Knocked It Out of the Park in Q1

Major Biotechs Face Rising Tide of Short Interest

Short Sellers Grow More Selective on Major Pharma Stocks

Why Eli Lilly’s Big Earnings Beat, Rosy Guidance Were Not Enough

Unity Biotech Announces Potential Pricing for IPO

Can Epizyme Survive This FDA Hold?

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Health and Healthcare Articles

All Health and Healthcare Articles

Will a PCSK9 Inhibitor Price Cut Help Drive Lowering LDL-Cholesterol Drug Use?

Will Gilead Sciences Earnings Get a Boost From a Collaboration?

Why One Old Stock Buyback Trick Is Working So Well for AbbVie

How Keytruda Saved Merck’s Q1

How Much Pfizer Earnings Depend on a Few Brands

What to Look For in the Merck and Pfizer Reports Tuesday Morning

Evelo Announces Potential Pricing for IPO

Why SteadyMed Shares Are Skyrocketing

Johnson & Johnson Commits to Yet Another Dividend Hike

How Alexion Pharmaceuticals Knocked It Out of the Park in Q1

Major Biotechs Face Rising Tide of Short Interest

Short Sellers Grow More Selective on Major Pharma Stocks

Why Eli Lilly’s Big Earnings Beat, Rosy Guidance Were Not Enough

Unity Biotech Announces Potential Pricing for IPO

Can Epizyme Survive This FDA Hold?

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%

Featured Reads

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how